Azetidinecarboxylic Acid
Molecular Sequence Data
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Heat-Shock Proteins
Amino Acid Sequence
Heat-Shock Response
Models, Molecular
Research
Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed)
Egypt
Schistosomiasis
Infection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States.
Biomedical Research
Aziridines
Rhodium
Sulfonium Compounds
Azirines
Disopyramide
Spiramycin
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Prenylamine
Anesthetics, Local
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.
Lidocaine
Anesthetics
Cimicidae
Civil Rights
Histiocytosis, Sinus
Africa, Southern
Williams Syndrome
A disorder caused by hemizygous microdeletion of about 28 genes on chromosome 7q11.23, including the ELASTIN gene. Clinical manifestations include SUPRAVALVULAR AORTIC STENOSIS; MENTAL RETARDATION; elfin facies; impaired visuospatial constructive abilities; and transient HYPERCALCEMIA in infancy. The condition affects both sexes, with onset at birth or in early infancy.
Influenza A virus
The type species of the genus INFLUENZAVIRUS A that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces.
Influenza, Human
Hemagglutinin Glycoproteins, Influenza Virus
Membrane glycoproteins from influenza viruses which are involved in hemagglutination, virus attachment, and envelope fusion. Fourteen distinct subtypes of HA glycoproteins and nine of NA glycoproteins have been identified from INFLUENZA A VIRUS; no subtypes have been identified for Influenza B or Influenza C viruses.
Hemagglutinins
Influenza A Virus, H1N1 Subtype
Influenza A Virus, H3N2 Subtype
Lymphoma, Mantle-Cell
A form of non-Hodgkin lymphoma having a usually diffuse pattern with both small and medium lymphocytes and small cleaved cells. It accounts for about 5% of adult non-Hodgkin lymphomas in the United States and Europe. The majority of mantle-cell lymphomas are associated with a t(11;14) translocation resulting in overexpression of the CYCLIN D1 gene (GENES, BCL-1).
Oxidative Phosphorylation
Bell Palsy
A syndrome characterized by the acute onset of unilateral FACIAL PARALYSIS which progresses over a 2-5 day period. Weakness of the orbicularis oculi muscle and resulting incomplete eye closure may be associated with corneal injury. Pain behind the ear often precedes the onset of paralysis. This condition may be associated with HERPESVIRUS 1, HUMAN infection of the facial nerve. (Adams et al., Principles of Neurology, 6th ed, p1376)
Effect of L-azetidine-2-carboxylic acid on glycosylations of collagen in chick-embryo tendon cells. (1/17)
The glycosylations of hydroxylysine during collagen biosynthesis in isolated chick-embryo tendon cells were studied by using pulse-chase labelling experiments with [14C]-lysine. The hydroxylation of lysine and the glycosylations of hydroxylysine continued after a 5 min pulse label for up to about 10 min during the chase period. These data differ from those obtained previously in isolated chick-embryo cartilage cells, in which, after a similar 5 min pulse label, these reactions continued during the chase period for up to about 20 min. The collagen synthesized by the isolated chick-embryo tendon cells differed markedly from the type I collagen of adult tissues in its degree of hydroxylation of lysine residues and glycosylations of hydroxylysine residues. When the isolated tendon cells were incubated in the presence of L-azetidine-2-carboxylic acid, the degree of glycosylations of hydroxylysine during the first 10 min of the chase period was identical with that in cells incubated without thcarboxylic acid for at least 60 min, whereas no additional glycosylations took place in the control cells after the 10 min time-point. As a consequence, the collagen synthesized in the presence of this compound contained more carbohydrate than did the collagen synthesized by the control cells. Additional experiments indicated that azetidine-2-carboxylic acid did not increase the collagen glycosyltransferase activities in the tendon cells or the rate of glycosylation reactions when added directly to the enzyme incubation mixture. Control experiments with colchicine indicated that the delay in the rate of collagen secretion, which was observed in the presence of azetidine-2-carboxylic acid, did not in itself affect the degree of glycosylations of collagen. The results thus suggest that the increased glycosylations were due to inhibition of the collagen triple-helix formation, which is known to occur in the presence of azetidine-2-carboxylic acid. (+info)Incorporation of L-azetidine-2-carboxylic acid into hemoglobin in rabbit reticulocytes in vitro. (2/17)
L-Azetidine-2-carboxylic acid is the naturally occurring lower homologue of L-proline. Reticulocytes from anemic rabbits incubated with DL-[14-C]azetidine-2-carboxylic acid synthesized radiolabeled hemoglobin, which when isolated from cell lysates co-chromatographed with unlabeled hemoglobin on Sephadex G-100 columns. Amino acid analysis of hemoglobin from reticulocytes incubated with DL-[14-C]-azetidine-2-carboxylic acid suggested that the homologue was incorporated into hemoglobin intact and unaltered. Alternatively, another amino acid analogue, 1-aminocyclopentane-[1-14-C]carboxylic acid, which is purported to be a valine antagonist, was not incorporated into hemoglobin under these conditions. Incubation of reticulocytes with 1, 5, and 10 mM L-azetidine-2-carboxylic acid reduced L-[U-14-C]proline (0.10 mM) incorporation into hemoglobin by 25, 58, and 72%, respectively. Conversely, 1.45 and 145 muM L-proline reduced radiolabeled azetidine-2-carboxylic acid (0.8 mM) in corporation into hemoglobin by 45 and 92%, respectively. Incorporation of L-[U-14-C]leucine and L-[U-14-C]lysine (0.1 mM each) into hemoglobin was unaffected at these concentrations of L-azetidine-2-carboxylic acid. These results suggest that L-azetidine-2-carboxylic acid is incorporated into hemoglobin without reducing the rate of globin synthesis in rabbit reticulocytes in vitro. The alpha and beta chains of hemoglobin into which [14-C]azetidine-2-carboxylic acid had been incorporated in rabbit reticulocytes in vitro were resolved electrophoretically on sodium dodecyl sulfate-polyacrylamide gels. The ratio of total radioactivity in the alpha and beta chains separately extracted from gels was in good agreement with the known 7:4 ratio of prolyl residues in the respective chains. Autoradiograms of two-dimensional tryptic peptide maps of rabbit globin into which either [14-C]azetidine-2-carboxylic acid or [14-C]proline had been incorporated showed nearly identical patterns of radioactivity. These results suggest that azetidine-2-carboxylic acid substitutes specifically for prolyl residues during in vitro hemoglobin synthesis in rabbit reticulocytes. (+info)18F-ZW-104: a new radioligand for imaging neuronal nicotinic acetylcholine receptors--in vitro binding properties and PET studies in baboons. (3/17)
(+info)Antihypertensive effect of CS-905, a novel dihydropyridine calcium blocker, in conscious hypertensive dogs. (4/17)
CS-905, (+-)-3-(1-diphenylmethylazetidin-3-yl)5-isopropyl 2-amino-1,4-dihydro-6-methyl-4-(m-nitrophenyl)-3,5-pyridine-dicarboxy lat e, is a novel dihydropyridine calcium blocker. Both CS-905 and nicardipine, when administered orally, produced a dose-dependent fall of blood pressure in conscious perinephritic hypertensive dogs. Unlike the hypotensive effect of nicardipine, that of CS-905 has a gradual onset and is long-lasting, with little increase in the heart rate and plasma renin activity (PRA). The lack of both tachycardia and increase of PRA is probably mostly due to the slow onset of antihypertensive action following CS-905. (+info)Generation and electrophile trapping of N-Boc-2-lithio-2-azetine: synthesis of 2-substituted 2-azetines. (5/17)
(+info)Effects of a new thyrotropin-releasing hormone derivative on behavioral changes after focal cerebral ischemia in rats. (6/17)
We observed the effects of a new thyrotropin-releasing hormone derivative, YM-14673 (N alpha-[[(S)-4-oxo-2-azetidinyl]carbonyl]-L-histidyl-L-prolinamide dihydrate), on behavioral changes in rats for 3 weeks after focal cerebral ischemia. Under halothane anesthesia, the left middle cerebral artery was occluded via a transretro-orbital approach. YM-14673 was administered just after the operation and once a day for 3 weeks. Neurologic deficits, including hemiplegia and abnormal posture, and disturbance of passive avoidance learning were present in solvent-treated control rats for the entire 3 weeks. YM-14673 at 0.1 or 0.3 mg/kg i.p. or 1 mg/kg p.o. significantly accelerated the recovery of neurologic deficits and ameliorated cognitive disturbance compared with the solvent-treated controls although the drug at 0.1 and 0.3 mg/kg i.p. did not influence the size of the ischemic infarct. YM-14673 mitigated the behavioral disturbances in this model of chronic focal cerebral ischemia. We also discuss the suitability of this model for the evaluation of drugs. (+info)Beneficial renal effects of CS-905, a novel dihydropyridine calcium blocker, in SHR. (7/17)
CS-905 is a potent dihydropyridine calcium blocker that has a gradual and long-lasting antihypertensive action with little tachycardia in SHR. In this study, we investigated chronic and acute effects of CS-905 on renal functions in SHR. To examine the chronic effects, 23 week-old male SHR were treated with CS-905 (1 or 3 mg/kg/day, p.o.) or 0.3% CMC (carboxymethylcellulose). After the 15 week-treatment, the agent dose-relatedly lowered systolic blood pressure measured 24 hr after the final administration (184 +/- 2 and 173 +/- 3 mmHg at 1 and 3 mg/kg/day vs. 218 +/- 4 mmHg for the control group). Natriuresis and the reduction of urinary protein excretion were also observed in the CS-905 treated groups. Urinary NAG (N-acetyl-beta-D-glucosaminidase) activity tended to decrease, but not significantly. Histopathological changes observed in the SHR kidney were reduced by chronic treatment with CS-905. On a single oral administration in 38 week-old SHR, CS-905 caused natriuresis at a dose of 3 mg/kg, but did not affect urinary protein excretion and urinary NAG activity. These effects of CS-905 on renal functions may be beneficial in the treatment of hypertension. (+info)Interference with thyroid histogenesis by inhibitors of collagen synthesis. (8/17)
Histogenesis of thyroid follicles in the chick embryo begins with a penetration by cells of the mesenchymal capsule into a solid epithelial primordium. Before penetration occurs, slits containing fibrillar material form between the epithelial cells. The fibrillar material is an epithelial cell product as shown by its formation within channels that form in cultures of isolated epithelial primordia. The drugs L-azetidine-2-carboxylic acid (LACA) and alpha, alpha'-dipyridyl, which interfere with collagen synthesis, prevent the formation of fibrils in cultured epithelial primordia and in cultures of whole thyroids. Furthermore, mesenchymal cells do not invade when whole thyroid primordia are cultured in the presence of either drug. The effects of alpha, alpha'-dipyridyl are reversed by washing out the drug; the effects of LACA are reversed by incubation with equimolar or greater amounts of L-proline added to the medium along with the drug. The results are interpreted to mean that the fibrillar material is collagen of epithelial origin, that the collagen in some way plays a role in mesenchymal penetration of the epithelial primordium, and that the epithelium is responsible for the pattern of lobulation within the developing gland. (+info)
2R,4S)-N-BOC-4-Hydroxypiperidine-2-carboxylic acid methyl ester, 95%, 98% ee, ACROS Organics™ 1g; Glass bottle (2R,4S)-N-BOC-4...
Alfa Aesar™ N-Boc-3-iodo-L-alanine methyl ester, 98% 250mg Alfa Aesar™ N-Boc-3-iodo-L-alanine methyl ester, 98%
| Fisher...
Alfa Aesar™ N-Boc-2,4-dichloro-D-phenylalanine, 98% 1g Alfa Aesar™ N-Boc-2,4-dichloro-D-phenylalanine, 98%
Alfa Aesar™ N-Boc-2-bromo-L-phenylalanine, 95% 1g Alfa Aesar™ N-Boc-2-bromo-L-phenylalanine, 95%
Amlodipine. - Keyboard Exploit
1S,2R,4S)-N-Boc-1-amino-2-hydroxycyclopentane-4-carboxylic acid methyl ester - Alfa Chemistry
R)-N-Boc-1-[4-(tert-butyldimethylsilyloxymethyl)cyclohexyl]ethan-1-amine biochemical product blog
N-Boc-(2S,3S)-3-Amino-2-hydroxy-3-(3-methyl-phenyl)-propanoic acid - Alfa Chemistry
CAS # 55447-00-2, (S)-N-Boc-1-Naphthylalanine, N-tert-Butoxycarbonyl-1-naphthyl-L-alanine
Publications | Page 2 | Knowledge Discovery and Data Mining Laboratory
Community Partners in Action Publications Page 3
N-Boc-3-piperidineacetic acid|183483-09-2|Xinkai
N-Boc-2-piperidineacetic acid|149518-50-3|Xinkai
Subject: regioselectivity / Publication Year: 2015 / Subject: chemical structure - PubAg Search Results
Hard to make space: improving access to privileged pharmacophores - University of Huddersfield Repository
The new coronary vasodilators: calcium blockers<...
EPO - T 0573/03 (Azetidine-2-carboxylic acid/ASTRAZENECA) of 2.8.2005
4-[4-Oxo-3-(phenylsulfanyl)-3,4-dihydro-1H,2H-spiro[azetidine-2,1-naphthalen]-1-yl]benzaldehyde | C25H21NO2S | ChemSpider
Cas Number Listed 1 Nicosulfuron, 1-N-Boc-3-hydroxyazetidine, 1-Piperidinecarboxylicacid, 3-hydroxy-, 1,1-dimethylethyl ester, ...
ESR3 - EV glycosylations as therapeutic and diagnostic targets of prostate cancer - proEVLifeCycle
Somapacitan - AdisInsight
Amlodipine 2.5mg Prix - Pharmacie Internet Suisse - Carolina Gamefowl
Owned: false BS article published in the Martialist - Page 13
Owned: false BS article published in the Martialist - Page 15
Plus it
Indian Patents. 253572:13-(N-BOC-ß-ISOBUTYLSERINYL) -14 ß-HYDROXYBACCATINE V 1, 14 OF FORMULA (I) AND COMPOSITIONS THEREOF
S)-azetidine-2-carboxylic acid... - Registration Dossier - ECHA
Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence. | Sigma-Aldrich
Chemical glycobiology: new methods for stereoselective and automated glycosylations in the synthesis of biologically relevant...
Bb LABORATORIES
Verapamil - Healthery
Protecting Yourself in Hostile Environments
Shortys Sutures: Note to Self: Self-Protection is Key
TCDB » SEARCH
Blog | Clubb Chimera | Page 94
hope | Metroplex Counseling
Effects of beta-aminopropionitrile, L-azetidine-2-carboxylic acid and beta-xyloside on the tunica media of the developing chick...
Olfactory bulbectomy induced oxidative and cell damage in rat: Protective effect of melatonin<...
JAIRO | Volatile Glycosylation in Tea Plants: Sequential Glycosylations for the Biosynthesis of Aroma β-Primeverosides Are...
Martial arts, fighting or self-protection? | Iain Abernethy
Nucleosides and Nucleotides. 208. Alternate-Strand Triple-Helix Formation by the 3-3-Linked Oligodeoxynucleotides with the...
Tackling the glycosylation of 2-deoxy-sugars: A reagent-controlled approach utilizing cyclopropenium cations for the α...
PPT - Guns PowerPoint Presentation - ID:2815
codeblog
Sensitive Soothing Scalp Restorer
Components updated in Dr.Web 12.0 products for Windows
Muay Thai Self-Defence (dairy) | Clubb Chimera
Grenfell Tower - a fatal case of institutional paralysis - The New Observer
SESSION FULL REGISTRATION CLOSED - Live Online - UMAB - One Day Verbal De-escalation Training | Toronto Hostels Training Centre
silicon advocate- pheromone concerns - New Pheromone User Guide - Perfume Chat and Trading Post
Boettcher : Group : Prof. Dr. J. Thiem : Emeriti und Ehemalige : Organic Chemistry : Universität Hamburg
CombatiX FAQ
Inflammation - The School of Biomedical Sciences Wiki
Triple Blood Balance Review: Legit Advanced Natural Formula? | Nhadat24
Detection of [1,6-13C2]-glucose metabolism in rat brain by in vivo 1H-[13C]-NMR spectroscopy
Gratitude Gourmet Blog - Gratitude Gourmet
Alfred Hassner
Hassner's group pioneered in methodology for synthesis of small ring heterocycles such as aziridines, azirines, azetines, as ...
The synthesis of azabicyclo[4.2.1]nonenes by the addition of a cyclopropenone to 4-vinyl substituted 1-azetines-isomers of the...
The synthesis of azabicyclo[4.2.1]nonenes by the addition of a cyclopropenone to 4-vinyl substituted 1-azetines-isomers of the ... The conversion of the 4-vinyl β-lactams 6 into the corresponding 2-ethoxy-1-azetines was unsuccessful. 13 G. Pifferi, P. ... The conversion of 4-vinyl substituted β-lactams into 4-vinyl substituted 1-azetines and their subsequent reaction with ... nonenes by the addition of a cyclopropenone to 4-vinyl substituted 1-azetines-isomers of the homotropane nucleus. Tetrahedron ...
Azetidinecarboxylic Acid | Harvard Catalyst Profiles | Harvard Catalyst
Synthesis of 4- to 7-membered Heterocycles by Ring Expansion | Springer for Research & Development
Alfred Hassner - Wikipedia
KAKEN - Research Projects | Creation of Innovative Organocatalysts Using the Network of Intermolecular Interactions (KAKENHI...
Index Catalog // Tesis y Disertaciones Electrónicas de Emory
Index Catalog // Emory Electronic Theses and Dissertations
Identifying signaling molecules from Gram-positive bacteria | Nature Research Chemistry Community
Azetidines | Colorado PROFILES
Hard to make space: improving access to privileged pharmacophores - University of Huddersfield Repository
DeCS
No questions in Disopyramide - lookformedical.com
No questions in Glycopyrrolate - lookformedical.com
DeCS Ingl s+escopo
Find Research outputs
- University of Huddersfield Research Portal
Hassner Alfred | Department of Chemistry
Ximelagatran - DrugBank
新闻详细--上海交大化学化工学院
Supervisors
Piperazines | Profiles RNS
Townsend EC, Murakami MA, Christodoulou A, Christie AL, Köster J, DeSouza TA, Morgan EA, Kallgren SP, Liu H, Wu SC, Plana O, Montero J, Stevenson KE, Rao P, Vadhi R, Andreeff M, Armand P, Ballen KK, Barzaghi-Rinaudo P, Cahill S, Clark RA, Cooke VG, Davids MS, DeAngelo DJ, Dorfman DM, Eaton H, Ebert BL, Etchin J, Firestone B, Fisher DC, Freedman AS, Galinsky IA, Gao H, Garcia JS, Garnache-Ottou F, Graubert TA, Gutierrez A, Halilovic E, Harris MH, Herbert ZT, Horwitz SM, Inghirami G, Intlekoffer AM, Ito M, Izraeli S, Jacobsen ED, Jacobson CA, Jeay S, Jeremias I, Kelliher MA, Koch R, Konopleva M, Kopp N, Kornblau SM, Kung AL, Kupper TS, LaBoeuf N, LaCasce AS, Lees E, Li LS, Look AT, Murakami M, Muschen M, Neuberg D, Ng SY, Odejide OO, Orkin SH, Paquette RR, Place AE, Roderick JE, Ryan JA, Sallan SE, Shoji B, Silverman LB, Soiffer RJ, Steensma DP, Stegmaier K, Stone RM, Tamburini J, Thorner AR, van Hummelen P, Wadleigh M, Wiesmann M, Weng AP, Wuerthner JU, Williams DA, Wollison BM, Lane AA, Letai ...
Search Articles | University of Toronto Libraries
Dioxins | Profiles RNS
Pyrrolidines | Colorado PROFILES
Heijerman HGM, McKone EF, Downey DG, Van Braeckel E, Rowe SM, Tullis E, Mall MA, Welter JJ, Ramsey BW, McKee CM, Marigowda G, Moskowitz SM, Waltz D, Sosnay PR, Simard C, Ahluwalia N, Xuan F, Zhang Y, Taylor-Cousar JL, McCoy KS. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial. Lancet. 2019 11 23; 394(10212):1940-1948 ...
Piperazines | REACH
Hodi FS, Corless CL, Giobbie-Hurder A, Fletcher JA, Zhu M, Marino-Enriquez A, Friedlander P, Gonzalez R, Weber JS, Gajewski TF, ODay SJ, Kim KB, Lawrence D, Flaherty KT, Luke JJ, Collichio FA, Ernstoff MS, Heinrich MC, Beadling C, Zukotynski KA, Yap JT, Van den Abbeele AD, Demetri GD, Fisher DE. Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. J Clin Oncol. 2013 Sep 10; 31(26):3182-90 ...
Pyrimidines | Profiles RNS
Zhang L, Yao Y, Zhang S, Liu Y, Guo H, Ahmed M, Bell T, Zhang H, Han G, Lorence E, Badillo M, Zhou S, Sun Y, Di Francesco ME, Feng N, Haun R, Lan R, Mackintosh SG, Mao X, Song X, Zhang J, Pham LV, Lorenzi PL, Marszalek J, Heffernan T, Draetta G, Jones P, Futreal A, Nomie K, Wang L, Wang M. Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma. Sci Transl Med. 2019 05 08; 11(491 ...
Pyrans | Profiles RNS
Thomas AA, Hunt KW, Volgraf M, Watts RJ, Liu X, Vigers G, Smith D, Sammond D, Tang TP, Rhodes SP, Metcalf AT, Brown KD, Otten JN, Burkard M, Cox AA, Do MK, Dutcher D, Rana S, DeLisle RK, Regal K, Wright AD, Groneberg R, Scearce-Levie K, Siu M, Purkey HE, Lyssikatos JP, Gunawardana IW. Discovery of 7-tetrahydropyran-2-yl chromans: ß-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors that reduce amyloid ß-protein (Aß) in the central nervous system. J Med Chem. 2014 Feb 13; 57(3):878-902 ...
Azirines2
- Hassner's group pioneered in methodology for synthesis of small ring heterocycles such as aziridines, azirines, azetines, as well as of larger ring heterocycles including azepines. (wikipedia.org)
- Advances have also been made in understanding the reactivity of azirines with rhodium carbenoids to generate azetines from successful ring expansion, or N-vinylimine from ring opening. (hud.ac.uk)
Synthesis1
- Part 1: Stereoselective Synthesis of Quaternary Center Bearing Azetines and β-Amino Acid Derivatives. (emory.edu)